Celldex Therapeutics | CLDX - Current Liabilities


Celldex Therapeutics reported $46.46M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
AbbVie USD 43.29B 3.9B Dec/2025
Agenus USD 287.13M 52.57M Sep/2025
Amgen USD 25.49B 3.7B Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Celldex Therapeutics USD 46.46M 13.5M Sep/2025
Glaxosmithkline GBP 28.68B 8.3B Sep/2025
Nektar Therapeutics USD 66.34M 5.05M Sep/2025
Northwest Biotherapeutics USD 87.9M 3.98M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Rigel Pharmaceuticals USD 94.4M 7.76M Sep/2025
Roche Holding CHF 28B 421M Dec/2025